Skip to main content

Table 5 Mutation detection rates in unilateral and bilateral RB patient groups studies across the globe

From: Retinoblastoma genetics screening and clinical management

S. nos

Author

Country

Type of mutations

Mutation detection rate BLRB (%)

Mutation detection rate ULRB

Year of study

02

Mohd Khalid, M.K., et al

Malaysia

Nonsense, Frame shift, Splice site and De-novo origin

100

25%

2015

05

Grotta et al.

Italy

Point mutations, Frame shift, Large deletions

96.5

22%

2015

09

Chen, Z., et al

USA

Nonsense, Splice, Frameshift

97

18%

2014

07

Price et al

United Kingdom

Point mutation, deletions, missense, splice site mutations

96

9.5%

2014

10

Seo, S.H., et al

Korea

Missense, nonsense, frameshift and splice

94.5

None

2013

11

Ottaviani, D., et al

Argentina

Nonsense, frameshift, missense, deletions

94

–

2013

08

Dommering, C.J., et al

Netherland

Nonsense, frameshift, splice, large indel, missense, chromosomal deletions and promoter

92

10%

2014

01

Frenkal.Set al

France

Stop codon, Splice site and large deletions

90

19.8%

2016

15

Macias, M., et al

Mexico

Nonsense, Splice, Frameshift

76.9

34.8%

2008

16

Abouzeid et al

Switzerland

Nonsense, frameshift, missense, deletions

73

10.7%

2007

03

Zhang, L., et al

China

Nonsense, Splice, Frameshift

65

35%

2015

06

Devarajan et al

India

Nonsense, Frame shift, Splice site and Denovo origin

63

37%

2015

04

Kalsoom, S., et al

Pakistan

Null mutation, deletions, missense, splice site mutations

45.7

54.3%

2015

12

Barbosa, R.H., et al

Brasil

Nonsense, Splice, Frameshift

42.2

56.3%

2013

14

Abidi et al.,

Morocco

Duplication, Deletion, Splice, Frameshift

40

None

2011

17

Choy et al

Hong kong & China

Nonsense, Splice, Frameshift

38

19%

2002

13

Ahani et al

Iran

Missense, frameshift and splice site

16.6

18.2%

2013

14

Present study—Himika, Malaichamy, et al

India

Missense, frameshift, gene deletions

86.2

19%

2020